Eye Health News and Research

Latest Eye Health News and Research

Bausch & Lomb announces acquisition of Tubilux Pharma's commercial assets

Bausch & Lomb, the global eye health company, today announced it has acquired the commercial assets of Tubilux Pharma S.p.A.

5 Oct 2009

Oral Cancer Foundation initiates program to donate VELscope screening systems

The Oral Cancer Foundation recently initiated a program of donating VELscope® Oral Cancer Screening Systems to free clinics and others located in, and helping communities with, underserved populations.

5 Oct 2009

New photographed and philosophical guide for sushi lovers

Sushi connoisseurs and novices alike will be delighted to indulge in Ole Mouritsen's new book, Sushi: Food for the Eye, the Body and the Soul, a beautifully photographed and philosophical guide for those who prepare and eat sushi.

5 Oct 2009

Top ten sleep and beauty tips

Bob Hickman, United Feather & Down's Senior Vice Present of Sales and Marketing, and Neil A. Petrocelli, Borghese, Inc.'s Vice President of Marketing, list their top sleep and beauty tips.

5 Oct 2009

Nationwide Children's Hospital study on burn injuries in kids

In the next 60 seconds, another child will be on his/her way to the hospital to be treated for serious burns; it happens more than 300 times a day in this country. Now, one of the largest studies ever done on burn injuries in kids is out from experts at Nationwide Children's Hospital and the results are mixed: while overall injuries are down, there are some kids who are still at serious risk.

5 Oct 2009

Genentech announces two Phase III study results of Lucentis

Genentech, Inc., a wholly-owned member of the Roche Group, today announced results from two Phase III studies of Lucentis (ranibizumab injection) in macular edema due to retinal vein occlusion (RVO), which showed, on average, patients given either of two doses of Lucentis had a clinically and statistically significant improvement in vision as measured by the primary endpoint of mean change from baseline in best-corrected visual acuity (BCVA) at six months compared to patients receiving sham injections.

5 Oct 2009

New study reveals that perception of color depends on biological processes of the eye and brain

Color is normally thought of as a fundamental attribute of an object: a red Corvette, a blue lake, a pink flamingo. Yet despite this popular notion, new research suggests that our perception of color is malleable, and relies heavily on biological processes of the eye and brain.

3 Oct 2009

Study finds that visual impairment in T1D patients may be decreasing

People diagnosed with type 1 diabetes (T1D) in recent years are less likely to develop diabetes-related vision loss than those diagnosed in earlier years, says a new study funded by the National Eye Institute, a division of the National Institutes of Health. Forecasts of visual impairment prevalence in T1D patients may need to be amended, the researchers suggest, since current predictions assume that the earlier incidence rates will continue.

3 Oct 2009

Falls are a major cause for eye injuries in the elderly

The most common fear for family members when an elderly relative falls is broken bones. But eye injuries can be just as serious and debilitating. Home is the where most eye injuries occur, and slips and falls are among the most common type of home injuries. Slippery stairs, loose railings, or sharp edges on furniture can lead to painful falls and devastating eye injuries for seniors, as well as children and other household members.

3 Oct 2009

Study points to subtle differences between boys and girls' attitudes to multiple drugs

New research by Weill Cornell Medical College researchers looks at the specific ways parents and peers influence teenagers to smoke, drink and use marijuana in combination.

3 Oct 2009

Vaccinate children with H1N1 flu vaccine to control swine flu: UAB

The optimal way to control swine flu, the new H1N1 virus that emerged as a global threat in 2009, is to vaccinate children with the planned H1N1 flu vaccine, says the co-director of the University of Alabama at Birmingham (UAB) Division of Pediatric Infectious Diseases.

3 Oct 2009

Clinical study data of Thymosin beta 4 presented

REGENERX BIOPHARMACEUTICALS, INC. today reported on several clinical studies with Thymosin beta 4 (Tβ4) presented the Second International Symposium on Thymosins in Health and Disease, in Catania, Italy.

3 Oct 2009

New health care ads hit the airwaves

The onslaught of health care advertising continues, with new ads from MoveOn.org, Organizing for America, the medical industry and Americans United for Change.

3 Oct 2009

Eye treatment reimbursement change could cost Medicare millions

A change in the reimbursement rate for the drug Avastin, used off-label to treat an eye illness in the elderly, could lead Medicare doctors to use a much costlier drug that would cost the system millions, The New York Times reports.

3 Oct 2009

New software to detect multiple sclerosis before brain damage occurs

Researchers of the Unit for Systems Biology of the University of Jaén, led by Francisco J. Esteban, are developing a software for clinical use to detect multiple sclerosis even before the typical brain damage of this neurodegenerative disease appear. In order to do so, this scientific multidisciplinary team is calculating the fractal dimension of the brain images registered on magnetic resonance imaging.

1 Oct 2009

Scientific Advisory Board to provide guidance to support the development of FST-100

Foresight Biotherapeutics announced today the formation of its scientific advisory board to provide guidance to the company for the development of it’s lead product FST-100, a novel formulation of dexamethasone that includes povidone-iodine. Foresight’s Scientific Advisory Board is comprised of leaders in the field of Ophthalmology.

1 Oct 2009

Fovea Pharmaceuticals to sell 100% of its share to Sanofi-Aventis

Fovea Pharmaceuticals announced today that it has entered into a binding agreement with sanofi-aventis to sell 100% of its share to sanofi-aventis. Fovea has a portfolio of three clinical compounds, a unique technology platform and several discovery programs dedicated to back of the eye diseases.

1 Oct 2009

Health information technology can improve health care for Americans living in rural communities

HHS Secretary Kathleen Sebelius today released a report on how health information technology can improve health care for Americans living in rural communities. The report examines how the Columbia Basin Health Association in Othello, Wash., uses health information technology to improve health care quality and patient safety as well as promote care coordination and continuity. The complete report is available now at www.healthreform.gov.

1 Oct 2009

NAACP endorses optometric vision therapy at its 100th Anniversary Convention

A routine visit to the eye doctor resulted in a national resolution that was passed by the NAACP at its 100th Anniversary Convention held in New York City, endorsing optometric vision therapy as a way to help some prisoners become productive members of society.

1 Oct 2009

10-point checklist from eHealthInsurance

eHealthInsurance, the leading online source of health insurance for individuals, families and small businesses, today, released a 10-point checklist to help employees make informed decisions about health insurance during the traditional annual open enrollment period.

1 Oct 2009